TLR4 and ocular melanoma: Using omeprazole (OM) as a representative PPI, we found that OM could potently inhibit multiple endosomal TLRs, including TLR3, TLR4, and TLR7/8, and reduce the downstream pro‐inflammatory cytokine production.